A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation

Atrial arrhythmias are common in patients with diabetes mellitus (DM), and despite recent advances in pharmaceutical and invasive treatments, atrial fibrillation (AF) and atrial flutter (AFl) are still associated with substantial mortality and morbidity. Clinical trial data imply a protective effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamichalakis, Nikolaos, Kolovos, Vasileios, Paraskevaidis, Ioannis, Tsougos, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331782/
https://www.ncbi.nlm.nih.gov/pubmed/35893226
http://dx.doi.org/10.3390/jcdd9080236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331782/
https://www.ncbi.nlm.nih.gov/pubmed/35893226
http://dx.doi.org/10.3390/jcdd9080236

Ejemplares similares